4.5 Article

An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer

Journal

BREAST CANCER RESEARCH
Volume 17, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s13058-015-0638-4

Keywords

-

Categories

Funding

  1. Wellcome Trust [105104/Z/14/Z]
  2. NIH [P01 CA91955, R01 CA149566, R01 CA170595, R01 CA185138, R01 CA140657, F32 CA144331]
  3. CDMRP Breast Cancer Research Program Award [BC132057]
  4. Breast Cancer Now [SF01]
  5. National Institute for Health Research (NIHR) Biomedical Research Centre
  6. Breast Cancer Campaign [2011MaySF01] Funding Source: researchfish
  7. Wellcome Trust [105104/Z/14/Z] Funding Source: researchfish

Ask authors/readers for more resources

Introduction: Abundance of immune cells has been shown to have prognostic and predictive significance in many tumor types. Beyond abundance, the spatial organization of immune cells in relation to cancer cells may also have significant functional and clinical implications. However there is a lack of systematic methods to quantify spatial associations between immune and cancer cells. Methods: We applied ecological measures of species interactions to digital pathology images for investigating the spatial associations of immune and cancer cells in breast cancer. We used the Morisita-Horn similarity index, an ecological measure of community structure and predator-prey interactions, to quantify the extent to which cancer cells and immune cells colocalize in whole-tumor histology sections. We related this index to disease-specific survival of 486 women with breast cancer and validated our findings in a set of 516 patients from different hospitals. Results: Colocalization of immune cells with cancer cells was significantly associated with a disease-specific survival benefit for all breast cancers combined. In HER2-positive subtypes, the prognostic value of immune-cancer cell colocalization was highly significant and exceeded those of known clinical variables. Furthermore, colocalization was a significant predictive factor for long-term outcome following chemotherapy and radiotherapy in HER2 and Luminal A subtypes, independent of and stronger than all known clinical variables. Conclusions: Our study demonstrates how ecological methods applied to the tumor microenvironment using routine histology can provide reproducible, quantitative biomarkers for identifying high-risk breast cancer patients. We found that the clinical value of immune-cancer interaction patterns is highly subtype-specific but substantial and independent to known clinicopathologic variables that mostly focused on cancer itself. Our approach can be developed into computer-assisted prediction based on histology samples that are already routinely collected.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available